Schedule 13D ownership disclosure

INVENTIVA SA

Ordinary Shares, nominal value EUR0.01 per share · CUSIP: 46124U107

Event date: 2024-12-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIOTECHNOLOGY VALUE FUND L PReported CIK 0000918923

    Shares: 4,630,461.00 · Class: 4.9%

  • BVF I GP LLCReported CIK 0001803805

    Shares: 4,630,461.00 · Class: 4.9%

  • BIOTECHNOLOGY VALUE FUND II LPReported CIK 0001102444

    Shares: 3,321,861.00 · Class: 3.5%

  • BVF II GP LLCReported CIK 0001803806

    Shares: 3,321,861.00 · Class: 3.5%

  • BIOTECHNOLOGY VALUE TRADING FUND OS, L.P.Reported CIK 0001660683

    Shares: 397,086.00 · Class: 0.4%

  • BVF Partners OS Ltd.Reported CIK 0001660684

    Shares: 397,086.00 · Class: 0.4%

  • BVF GP HOLDINGS LLCReported CIK 0001803809

    Shares: 7,952,322.00 · Class: 8.4%

  • BVF PARTNERS L P/ILReported CIK 0001055947

    Shares: 8,545,499.00 · Class: 9.0%

  • BVF INC/ILReported CIK 0001056807

    Shares: 8,545,499.00 · Class: 9.0%

  • LAMPERT MARK NReported CIK 0001233840

    Shares: 8,545,499.00 · Class: 9.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-24-003019
Form type
SCHEDULE 13D/A
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
Dec 23, 2024
Reporting period
Dec 19, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub